Proposed Rules Address Prescription Drug Pricing

Last week, the Department of Health and Human Services (HHS) released a proposed rule to lower prescription drug prices and out-of-pocket costs by encouraging manufacturers to pass discounts directly to patients and bring new transparency to prescription drug markets.

Please note, nothing has changed yet, as this is only a proposed rule.
Even if finalized in its current form, the proposed rule does not impact employer-sponsored plans unless Pharmacy Benefit Managers (PBMs) and pharmaceutical manufacturers adopt a new safe harbor, which may provide additional transparency.
If you need further information, visit:

For background and further information, contact your USI Northeast consultant.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s